Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex for Street Fitness in Surgical Patients
NCT01453530Phase 4Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2011
- Primary completion
- Sep 2012
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Sugammadex in neuromuscular blockade (NMB) (3 arms), sponsored by Radboud University Medical Center. Primary endpoint: Street Fitness in surgical patients undergoing general anesthesia after reversal of neuromuscular rest blockade. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT01453530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01453530.